Acrivon Therapeutics, Inc.
ACRV
$1.34
$0.010.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -85.96M | -83.75M | -80.56M | -76.98M | -69.00M |
| Total Depreciation and Amortization | 1.20M | 1.09M | 1.01M | 852.00K | 734.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.44M | 12.13M | 11.44M | 10.96M | 10.94M |
| Change in Net Operating Assets | 486.00K | 2.41M | 2.44M | 4.49M | 4.17M |
| Cash from Operations | -70.83M | -68.12M | -65.67M | -60.68M | -53.16M |
| Capital Expenditure | -2.37M | -2.01M | -2.77M | -3.09M | -2.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.46M | -36.40M | -49.00M | -42.56M | -58.04M |
| Cash from Investing | 69.09M | -38.41M | -51.77M | -45.65M | -60.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.00K | 70.01M | 70.09M | 70.41M | 70.48M |
| Repurchase of Common Stock | -2.29M | -2.70M | -2.52M | -3.17M | -1.97M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -307.00K | 53.55M | 53.46M | 52.43M | 52.74M |
| Cash from Financing | -2.59M | 120.86M | 121.03M | 119.66M | 121.25M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.33M | 14.33M | 3.59M | 13.34M | 7.95M |